人間ドック受診者におけるN-terminal pro-brain natriuretic peptide測定の意義

[1]  D. Levy,et al.  Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.

[2]  C. Hamm,et al.  Ischemia triggers BNP expression in the human myocardium independent from mechanical stress. , 2010, International journal of cardiology.

[3]  M. Sokolow,et al.  The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. , 1949, American heart journal.

[4]  Paul M Ridker,et al.  Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? , 2004, Circulation.

[5]  R. Rodeheffer,et al.  Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide: Biomarkers for Mortality in a Large Community-Based Cohort Free of Heart Failure , 2006, Hypertension.

[6]  P. Elliott,et al.  A combination of serum low albumin and above-average cholesterol level was associated with excess mortality. , 2004, Journal of clinical epidemiology.

[7]  D. Fukai,et al.  Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.

[8]  S. Kaufman,et al.  The influence of reproductive hormones on ANF release by rat atria. , 1993, Life sciences.

[9]  G Olivetti,et al.  Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. , 1991, Circulation research.

[10]  Daniel A Dalenberg,et al.  Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone. , 2009, Clinical chemistry.

[11]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[12]  W. Jiménez,et al.  Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes. , 2009, American journal of physiology. Heart and circulatory physiology.

[13]  P. Hildebrandt,et al.  Amino-terminal pro-B-type natriuretic peptide testing in patients with diabetes mellitus and with systemic hypertension. , 2008, The American journal of cardiology.

[14]  C. Hamm,et al.  Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine , 2005, Heart.

[15]  M. Cowie,et al.  The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study , 2005, European journal of heart failure.

[16]  M. Drazner,et al.  B-type natriuretic peptide in cardiovascular disease , 2003, The Lancet.

[17]  M. Nieminen,et al.  Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. , 1998, Hypertension.

[18]  K. Kangawa,et al.  Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP) , 1984 .

[19]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[20]  J. D. de Lemos,et al.  Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. , 2007, Journal of the American College of Cardiology.

[21]  Naoto Minamino,et al.  A new natriuretic peptide in porcine brain , 1988, Nature.

[22]  C. Bulpitt,et al.  Anti‐androgens increase N‐terminal pro‐BNP levels in men with prostate cancer , 2008, Clinical endocrinology.